These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 24007948)
1. Adult granulosa cell tumours (GCT): clinicopathological outcomes including FOXL2 mutational status and expression. Rosario R; Wilson M; Cheng WT; Payne K; Cohen PA; Fong P; Shelling AN Gynecol Oncol; 2013 Nov; 131(2):325-9. PubMed ID: 24007948 [TBL] [Abstract][Full Text] [Related]
2. A current perspective on the pathological assessment of FOXL2 in adult-type granulosa cell tumours of the ovary. Kommoss S; Gilks CB; Penzel R; Herpel E; Mackenzie R; Huntsman D; Schirmacher P; Anglesio M; Schmidt D; Kommoss F Histopathology; 2014 Feb; 64(3):380-8. PubMed ID: 24192202 [TBL] [Abstract][Full Text] [Related]
3. Mutational analysis of FOXL2 codon 134 in granulosa cell tumour of ovary and other human cancers. Kim MS; Hur SY; Yoo NJ; Lee SH J Pathol; 2010 Jun; 221(2):147-52. PubMed ID: 20198651 [TBL] [Abstract][Full Text] [Related]
4. Ovarian cellular fibromas lack FOXL2 mutations: a useful diagnostic adjunct in the distinction from diffuse adult granulosa cell tumor. McCluggage WG; Singh N; Kommoss S; Huntsman DG; Gilks CB Am J Surg Pathol; 2013 Sep; 37(9):1450-5. PubMed ID: 23774170 [TBL] [Abstract][Full Text] [Related]
5. The role of FOXL2 in the pathogenesis of adult ovarian granulosa cell tumours. Rosario R; Cohen PA; Shelling AN Gynecol Oncol; 2014 May; 133(2):382-7. PubMed ID: 24342437 [TBL] [Abstract][Full Text] [Related]
6. FOXL2 C402G mutation detection using MALDI-TOF-MS in DNA extracted from Israeli granulosa cell tumors. Gershon R; Aviel-Ronen S; Korach J; Daniel-Carmi V; Avivi C; Bar-Ilan D; Barshack I; Meirow D; Ben-Baruch G; Cohen Y Gynecol Oncol; 2011 Sep; 122(3):580-4. PubMed ID: 21640373 [TBL] [Abstract][Full Text] [Related]
7. Mutation of FOXL2 in granulosa-cell tumors of the ovary. Shah SP; Köbel M; Senz J; Morin RD; Clarke BA; Wiegand KC; Leung G; Zayed A; Mehl E; Kalloger SE; Sun M; Giuliany R; Yorida E; Jones S; Varhol R; Swenerton KD; Miller D; Clement PB; Crane C; Madore J; Provencher D; Leung P; DeFazio A; Khattra J; Turashvili G; Zhao Y; Zeng T; Glover JN; Vanderhyden B; Zhao C; Parkinson CA; Jimenez-Linan M; Bowtell DD; Mes-Masson AM; Brenton JD; Aparicio SA; Boyd N; Hirst M; Gilks CB; Marra M; Huntsman DG N Engl J Med; 2009 Jun; 360(26):2719-29. PubMed ID: 19516027 [TBL] [Abstract][Full Text] [Related]
8. The C134W (402 C>G) FOXL2 mutation is absent in ovarian gynandroblastoma: insights into the genesis of an unusual tumour. Oparka R; Cassidy A; Reilly S; Stenhouse A; McCluggage WG; Herrington CS Histopathology; 2012 Apr; 60(5):838-42. PubMed ID: 22296244 [TBL] [Abstract][Full Text] [Related]
9. FOXL2 mutation and large-scale genomic imbalances in adult granulosa cell tumors of the ovary. Geiersbach KB; Jarboe EA; Jahromi MS; Baker CL; Paxton CN; Tripp SR; Schiffman JD Cancer Genet; 2011 Nov; 204(11):596-602. PubMed ID: 22200085 [TBL] [Abstract][Full Text] [Related]
10. Comparative study of microRNA regulation on FOXL2 between adult-type and juvenile-type granulosa cell tumours in vitro. Rosario R; Blenkiron C; Shelling AN Gynecol Oncol; 2013 Apr; 129(1):209-15. PubMed ID: 23280087 [TBL] [Abstract][Full Text] [Related]
11. Adult granulosa cell tumour-like areas occurring in ovarian epithelial neoplasms: report of a case series with investigation of FOXL2 mutation status. Singh N; Gilks CB; Huntsman DG; Smith JH; Coutts M; Ganesan R; McCluggage WG Histopathology; 2014 Apr; 64(5):626-32. PubMed ID: 24138090 [TBL] [Abstract][Full Text] [Related]
12. Mutational analysis of FOXL2 p.C134W and expression of bone morphogenetic protein 2 in Japanese patients with granulosa cell tumor of ovary. Oseto K; Suzumori N; Nishikawa R; Nishikawa H; Arakawa A; Ozaki Y; Asai H; Kawai M; Mizuno K; Takahashi S; Shirai T; Yamada-Namikawa C; Nakanishi M; Kajiyama H; Kikkawa F; Sugiura-Ogasawara M J Obstet Gynaecol Res; 2014 May; 40(5):1197-204. PubMed ID: 24689977 [TBL] [Abstract][Full Text] [Related]
13. Clinical relevance of Ki67 gene expression analysis using formalin-fixed paraffin-embedded breast cancer specimens. Yamamoto S; Ibusuki M; Yamamoto Y; Fu P; Fujiwara S; Murakami K; Iwase H Breast Cancer; 2013 Jul; 20(3):262-70. PubMed ID: 22362219 [TBL] [Abstract][Full Text] [Related]
14. FOXL2 is a sensitive and specific marker for sex cord-stromal tumors of the ovary. Al-Agha OM; Huwait HF; Chow C; Yang W; Senz J; Kalloger SE; Huntsman DG; Young RH; Gilks CB Am J Surg Pathol; 2011 Apr; 35(4):484-94. PubMed ID: 21378549 [TBL] [Abstract][Full Text] [Related]
15. FOXL2 mutations in granulosa cell tumors occurring in males. Lima JF; Jin L; de Araujo AR; Erikson-Johnson MR; Oliveira AM; Sebo TJ; Keeney GL; Medeiros F Arch Pathol Lab Med; 2012 Jul; 136(7):825-8. PubMed ID: 22742556 [TBL] [Abstract][Full Text] [Related]
16. The transcriptional targets of mutant FOXL2 in granulosa cell tumours. Rosario R; Araki H; Print CG; Shelling AN PLoS One; 2012; 7(9):e46270. PubMed ID: 23029457 [TBL] [Abstract][Full Text] [Related]
17. DICER1 and FOXL2 mutations in ovarian sex cord-stromal tumours: a GINECO Group study. Goulvent T; Ray-Coquard I; Borel S; Haddad V; Devouassoux-Shisheboran M; Vacher-Lavenu MC; Pujade-Laurraine E; Savina A; Maillet D; Gillet G; Treilleux I; Rimokh R Histopathology; 2016 Jan; 68(2):279-85. PubMed ID: 26033501 [TBL] [Abstract][Full Text] [Related]
18. Mutational analysis (c.402C>G) of the FOXL2 gene and immunohistochemical expression of the FOXL2 protein in testicular adult type granulosa cell tumors and incompletely differentiated sex cord stromal tumors. Hes O; Vaněček T; Petersson F; Grossmann P; Hora M; Perez Montiel DM; Steiner P; Dvořák M; Michal M Appl Immunohistochem Mol Morphol; 2011 Jul; 19(4):347-51. PubMed ID: 21293260 [TBL] [Abstract][Full Text] [Related]